Skip to content
Screener

Charles River Laboratories CRL Manufacturing — CapEx

Other segment segments

DSA
$20.43M+10.4%
RMS
$4.99M+37.1%

Similar metrics at other companies

OTT
OTTRManufacturing — CapEx
$3.52M+47.5%
National Health Investors logo
NHISHOP — CapEx
$108.29M+7,410%
National Health Investors logo
NHIInvestments — CapEx
$1.12M-98.7%
LKQ logo
LKQEurope — CapEx
$26M-3.7%
Huntington Ingalls Industries logo
HIIIngalls — CapEx
$16M0.0%
LKQ logo
LKQSpecialty — CapEx
$2M-33.3%

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Gross profit$349.0M-3.5%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$12.56B+70.1%
Enterprise value$15.36B+53.4%
P/S3.1×+1.3×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-6%
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:SegmentExpenditureAdditionToLongLivedAssets.

The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:21 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001100682-26-000118
Capital Expenditures / Three Months Ended:RMSDSAManufacturingUnallocated CorporateConsolidated
June 27, 2026$4,989$20,433$5,634$49$31,105
June 28, 20253,64018,50011,1611,99735,298
Six Months Ended:
June 27, 2026$16,557$57,942$11,908$606$87,013
June 28, 202510,92653,02128,4402,23594,622
Depreciation and amortization (1)
Three Months Ended:
June 27, 2026$15,733$41,633$7,389$2,535$67,290

Item 1. Financial Statements

FAQ

What is Charles River Laboratories's manufacturing — capex?
Charles River Laboratories (CRL) reported manufacturing — capex of $5.63M in Q2 2026.
How has Charles River Laboratories's manufacturing — capex changed year-over-year?
Charles River Laboratories's manufacturing — capex decreased by 49.5% year-over-year, from $11.16M to $5.63M.
What is the long-term trend for Charles River Laboratories's manufacturing — capex?
Over 2 years (2023 to 2025), Charles River Laboratories's manufacturing — capex has grown at a -15.6% compound annual growth rate (CAGR), from $58.13M to $41.43M.
What does manufacturing — capex mean?
Funds used by the manufacturing segment to acquire, upgrade, and maintain physical assets such as property, plants, and equipment. This reflects the segment's investment in long-term productive capacity.

Ask your AI about Charles River Laboratories's manufacturing — capex.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude